Sign In
Buy VCYT
$48.69
+0.89 (+1.86%)
At Close: Jun 03, 2026
Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom
08:43pm, Saturday, 08'th Jul 2023
AI is coming to biotech in a big way. From protein folding to drug screening, from studying cells to studying populations, the AI boom has long been an asset to biological research and drug discovery.
Veracyte to Participate in Upcoming Investor Conferences
05:00pm, Tuesday, 23'rd May 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc Stapley, chief executive officer, and Rebecca Chambers, chief financial officer, will participate
Veracyte, Inc. (VCYT) Q1 2023 Earnings Call Transcript
10:43pm, Thursday, 04'th May 2023
Veracyte, Inc. (NASDAQ:VCYT ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Shayla Gorman - Director of Investor Relations Marc Stapley - Chief Executive Officer Rebecca
Wall Street Analysts See a 40.19% Upside in Veracyte (VCYT): Can the Stock Really Move This High?
11:27am, Thursday, 27'th Apr 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 40.2% in Veracyte (VCYT). While the effectiveness of this highly sought-after metric is questionable, the posit
Veracyte to Release First Quarter 2023 Financial Results on May 4, 2023
05:00pm, Thursday, 13'th Apr 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the first quarter of 2023 after the close of market on Thursday,
7 Biotech Stocks That Could Be the Next Big Thing
11:44am, Wednesday, 15'th Mar 2023
While the concept of high-risk speculation seems particularly dangerous at this juncture, gamblers may nevertheless want to consider the merits of targeting potentially lucrative biotech stocks that c
Double-Digit Sales Growth: Is This Stock a Convincing Buy for Growth Investors?
09:30am, Friday, 10'th Mar 2023
Veracyte's revenue grew at a healthy clip in the fourth quarter. The genomic test company's financial health looks solid.
Veracyte to Participate in Upcoming Investor Conferences
05:00pm, Monday, 27'th Feb 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc Stapley, chief executive officer, and Rebecca Chambers, chief financial officer, will participate
Veracyte, Inc. (VCYT) Q4 2022 Earnings Call Transcript
12:13am, Thursday, 23'rd Feb 2023
Start Time: 16:30 January 1, 0000 5:29 PM ET Veracyte, Inc. (NASDAQ:VCYT ) Q4 2022 Earnings Conference Call February 22, 2023, 16:30 PM ET Company Participants Marc Stapley - CEO Rebecca Chambers - EV
Veracyte (VCYT) Reports Q4 Loss, Tops Revenue Estimates
07:34pm, Wednesday, 22'nd Feb 2023
Veracyte (VCYT) delivered earnings and revenue surprises of 66.67% and 6.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Veracyte to Release Fourth Quarter and Full-Year 2022 Financial Results on February 22, 2023
05:00pm, Monday, 06'th Feb 2023
SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the fourth quarter and full-year 2022 after the close of market
Best Momentum Stocks to Buy for January 24th
11:17am, Tuesday, 24'th Jan 2023
VIPS, VCYT and EVR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 24, 2023.
Better Long-Term Buy in 2023: Exact Sciences or Veracyte?
10:23am, Tuesday, 24'th Jan 2023
As cancer screenings are becoming covered more often, both companies stand to gain.
This Small-Cap Stock Is a No-Brainer Buy
06:10am, Wednesday, 18'th Jan 2023
This genomic test maker's stock was beaten down in 2022. But it could be heading for a rebound this year.
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
03:01pm, Thursday, 05'th Jan 2023 Benzinga
Upgrades
For Algonquin Power & Utilities Corp (NYSE:AQN), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Algonquin Power showed an EPS of $0.11, compared
